Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Annual Report · 10-K

Quantum Cyber N.V.

Annual Report

Filed Mar 31, 2026Accepted Mar 31, 2026, 5:27 PM EDTCIK 1874252Accession 0001213900-26-037676
Share

Company context

We are a public company under Dutch law. We were incorporated on March 8, 2021 as a private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) under Dutch law. We were formed to acquire PharmGenomics GmbH (“PharmGenomics”), a German company with limited liability, and we acquired PharmGenomics on September 20, 2021. On November 9, 2021, we converted into a Dutch public company with limited liability (naamloze vennootschap). The address for our principal place of business is Robert Koch Strasse 50, 55129 Mainz, Germany, and the telephone number is +49 6131 5542860.

Current securities

Historical securities (1)

Recent company filings

  1. 8-K/A filingSep 25, 2026
  2. Regulation FD DisclosureSep 25, 2026
  3. 10-Q filingAug 14, 2026
  4. 4 filingAug 12, 2026
  5. SCHEDULE 13G filingAug 10, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗